Te Arai Biofarma News and Activities

Te Arai Biofarma is owned by Sonoma Pharmaceuticals.

Sonoma Pharmaceuticals is a company listed under the stock ticker SNOA (US).

Sonoma Pharmaceuticals has a direct presence in 2 countries.

View the org chart displaying its 4 main executives

Most searched biographies at Te Arai Biofarma

• Jennifer Gravatt, Director
• Lance Gravatt, Chairman of the Board
• Scott Lissington, Director

Popular executive movements at Sonoma Pharmaceuticals

• Vanessa Jacoby has joined the company as Director  (posted on January 30 2026).
• Arturo Angel has joined the company as Senior Vice President of Regulatory, Quality and Product Development  (posted on January 30 2026).

Create your alert
to follow the executive moves at Te Arai Biofarma.

Sonoma Pharmaceuticals has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Te Arai Biofarma

Social media about Te Arai Biofarma

• Te Arai Biofarma on Wikipedia, Google News & Yahoo Finance
• Te Arai Biofarma on LinkedIn, X (Twitter) & YouTube